Inloggen
E-mail
Wachtwoord
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

PLURISTEM THERAPEUTICS INC.

(PSTI)
uitgestelde koers. Vertraagde tijd Nasdaq - 23/06 22:00:00
3.95 USD   +0.51%
04/05PLURISTEM THERAPEUTICS INC.† : Alliance Global Partners handhaaft koopadvies
MM
2019PLURISTEM THERAPEUTICS : REVERSE SPLIT: 1 voor 10
FA
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtNieuwsAanbevelingen door analystenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op PLURISTEM THERAPEUTICS INC.
03/06PLURISTEM THERAPEUTICS† : PSTI) Insider Makes Significant Share Sale
02/06PLURISTEM THERAPEUTICS INC† : Submission of Matters to a Vote of Security Holder..
01/06INSIDER TRENDS : Pluristem Therapeutics Insider Extends 90-Day Selling Trend
29/05PLURISTEM THERAPEUTICS† : PSTI) Insider Makes Significant Share Sale
27/05INSIDER TRENDS : Insider Prolongs 90-Day Selling Trend at Pluristem Therapeutics
25/05PLURISTEM THERAPEUTICS† : Gets 20 Million Euros Investment Tranche From European..
25/05PLURISTEM THERAPEUTICS INC† : Other Events (form 8-K)
25/05PLURISTEM THERAPEUTICS† : to Receive Ä20M Non-Dilutive Funding from the European..
06/05PLURISTEM THERAPEUTICS† : Management's Discussion and Analysis of Financial Cond..
04/05INSIDER TRENDS : Insider Sales Continue 90-Day Trend at Pluristem Therapeutics
04/05PLURISTEM THERAPEUTICS† : Analyst and investor call May 3, 2021- webcast & prese..
04/05PLURISTEM THERAPEUTICS† : Analyst and investor call May 3, 2021- webcast
04/05PLURISTEM THERAPEUTICS† : Analyst and investor call May 3, 2021- presentation
03/05PLURISTEM THERAPEUTICS INC† : Regulation FD Disclosure, Financial Statements and..
03/05PLURISTEM THERAPEUTICS† : Analyst and investor call May 3, 2021- webcast, presen..
29/04PLURISTEM THERAPEUTICS INC† : Other Events (form 8-K)
29/04PLURISTEM THERAPEUTICS† : reports positive topline Phase I results in innovative..
26/03PLURISTEM THERAPEUTICS INC† : Changes in Registrant's Certifying Accountant, Fin..
08/02PLURISTEM THERAPEUTICS† : Management's Discussion and Analysis of Financial Cond..
03/02PLURISTEM THERAPEUTICS INC† : Entry into a Material Definitive Agreement, Financ..
03/02PLURISTEM THERAPEUTICS† : Announces $30 Million Registered Direct Offering
02/02PLURISTEM THERAPEUTICS† : Plans to Offer 4.8 Million Shares to Institutional Inv..
02/02PLURISTEM THERAPEUTICS INC.† : Announces $30 Million Registered Direct Offering
28/01PLURISTEM THERAPEUTICS† : Announces Uplisting to the Nasdaq Global Market
27/01PLURISTEM THERAPEUTICS† : Announces Uplisting to the Nasdaq Global Marketģ
06/01PLURISTEM THERAPEUTICS INC† : Change in Directors or Principal Officers (form 8-..
06/01PLURISTEM THERAPEUTICS† : Announces Appointments of Two Directors to Board
2020PLURISTEM THERAPEUTICS† : Enters Collaboration with Pharmaceutical Company Innov..
2020PLURISTEM THERAPEUTICS† : Working With Innovare to Expand Ongoing Study of PLX C..
2020Pluristem Enters Collaboration With Pharmaceutical Company Innovare R&D to Ex..
2020SECTOR UPDATE : Health Care Stocks Caught Up in Afternoon Market Retreat
2020SECTOR UPDATE : Health Care Stocks Dragged Under Wednesday as Market Weakens
2020SECTOR UPDATE : Health Care
2020MIDDAY REPORT : Wall Street Softer, Key Indexes Retreats From Record Highs; Door..
2020PLURISTEM THERAPEUTICS INC† : Regulation FD Disclosure, Other Events, Financial ..
2020SECTOR UPDATE : Health Care Stocks Advance Premarket Wednesday
2020DOORDASH, GAMESTOP, PFIZER : What to Watch When the Stock Market Opens Today
2020PLURISTEM THERAPEUTICS† : Terminates Phase 3 Study of PLX-PAD in Critical Limb I..
2020Pluristem Announces DMC Recommendation Following Interim Analysis of its Phas..
2020INSIDER TRENDS : Insider Buying Added to with Purchase of Pluristem Therapeutics..
2020PLURISTEM THERAPEUTICS† : to Present Initial Results from Its Phase I HCT Study ..
2020PLURISTEM THERAPEUTICS INC† : Other Events (form 8-K)
2020PLURISTEM THERAPEUTICS† : to Present Initial Results from Its Phase I HCT Study ..
2020Pluristem to Present Initial Results from Its Phase I HCT Study with PLX-R18 ..
2020PLURISTEM THERAPEUTICS† : Management's Discussion and Analysis of Financial Cond..
2020INSIDER TRENDS : Insider Buying Added to with Purchase of Pluristem Therapeutics..
2020PLURISTEM THERAPEUTICS† : World Experts in Infectious Diseases and Critical Care..
2020PLURISTEM THERAPEUTICS† : World Experts in Infectious Diseases & Critical Care F..
2020World Experts in Infectious Diseases & Critical Care Form Pluristem's COVID-1..
2020PLURISTEM THERAPEUTICS† : Announces Clearance to Move Forward with Enrollment fo..
2020PLURISTEM THERAPEUTICS† : Announces Clearance to Move Forward with Enrollment fo..
2020Pluristem Announces Clearance to Move Forward with Enrollment for Cohort II i..
2020PLURISTEM THERAPEUTICS INC† : Other Events (form 8-K)
2020PLURISTEM THERAPEUTICS† : Expands its Phase II COVID-19 European Clinical Trial ..
2020Pluristem Expands its Phase II COVID-19 European Clinical Trial to Israel
2020PLURISTEM THERAPEUTICS† : Abu Dhabi Stem Cells Center and Pluristem Unveil Joint..
2020PLURISTEM THERAPEUTICS† : Abu Dhabi Stem Cells Center and Pluristem Unveil Joint..
2020Abu Dhabi Stem Cells Center and Pluristem Unveil Joint Projects at Malta Conf..
2020PLURISTEM THERAPEUTICS† : CEO Issues Shareholder Update
2020PLURISTEM THERAPEUTICS INC† : Other Events (form 8-K)
2020PLURISTEM THERAPEUTICS† : CEO Issues Shareholder Update
2020Pluristem CEO Issues Shareholder Update
2020PLURISTEM THERAPEUTICS† : Management's Discussion and Analysis of Financial Cond..
2020PLURISTEM THERAPEUTICS INC† : Other Events (form 8-K)
2020Pluristem Launches FDA-Cleared COVID-19 Expanded Access Program, Enabling Pat..
2020Pluristem Announces End of Patient Enrollment in its Phase I Hematology Study
2020Pluristem and Abu Dhabi Stem Cells Center Sign MOU to Collaborate in the Deve..
2020PLURISTEM THERAPEUTICS† : expands its COVID-19 program to Europe, receives IEP c..
2020PLURISTEM THERAPEUTICS† : Expands Reach of Its COVID-19 Program to Europe and Re..
2020PLURISTEM THERAPEUTICS INC† : Other Events (form 8-K)
2020Pluristem Expands its COVID-19 Program to Europe, Receives PEI Clearance to C..
2020PLURISTEM THERAPEUTICS INC† : Entry into a Material Definitive Agreement, Financ..
2020Pluristem CEO Issues Shareholder Update on Clinical Programs
2020PLURISTEM THERAPEUTICS INC† : Entry into a Material Definitive Agreement, Financ..
2020PLURISTEM THERAPEUTICS INC† : Change in Directors or Principal Officers, Submiss..
1  2Volgende
Volgende evenement op PLURISTEM THERAPEUTICS INC.
Komende gebeurtenissen in de sector